http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-9903783-A2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate | 1999-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3eea0bf3a2d9796efdafe374dc588c4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b4e5d412d1537fc44d0c158ac3fd81d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f07a1b6c1819433db3e1bec35ab9f8ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f068f25108990e489ae9a08818d883b0 |
| publicationDate | 2000-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-9903783-A2 |
| titleOfInvention | Dihydro- and tetrahydroquinoline derivatives, a process for their preparation and pharmaceutical compositions containing such compounds |
| abstract | The present invention relates to novel dihydrate and tetrahydroquinoline derivatives, to their preparation and to pharmaceutical compositions containing such compounds. In the general formula (I) of the compounds of the present invention, R1 represents a hydrogen atom or a (XI) generic tuber, and in the incubator A is a hydrogen atom or a -bBZ1Z2-formulated tuber, and in the present formula B is an alkylene coat, while Z1 and Z2 are each independently hydrogen or alkyl, cycloalkyl. - or, in the case of a given case, a scaled-down aryl tube coat, or, in the case of co-administration, a thyrostylic acid cycloalkyl or heteroaryl tuber with an antifungal gene to which it is attached; R 2 and R 3 are independently alkyl, cycloalkyl, cycloalkyl, optionally substituted aryl, substituted, substituted heterocyclyl, cycloalkylalkyl, heterocycloalkylalkyl, in the case of a displacement of arylalkyl, in the case of a substituted heteroarylalkyl, or a substituted aminoalkyl radical, or R2; and R 3 is a cyclic tube tube or, in the case of a supply, a cyclized tubular hollow core tube with a carbon barrel to which it engages; - R40 = H, optionally esetbenszűbsztitűált alkyl optionally szűbsztitűáltalkenilcsőpőrt, optionally substituted alkynyl, Q csőpőrtvagy -VQ group, and the latter two groups, A is an alkylene, alkenylene or alkynylene group and Q is an esetbenszűbsztitűált cycloalkyl, optionally substituted aryl - heterocyclylalkyl or substituted heterocyclic heterocyclic arylthiourophenyl radical, as defined in the claims, - R41 and R5 together represent a chemical bonding agent or each hydrogens; - R6, R7, R8 and R9 independently of one another are hydrogen or halo genes or alkyl, cycloalkyl, or -OW, and in the boiling formula, W is hydrogen or alkyl, acyl, cycloalkyl, heterocycloalkyl, substituted aryl. , in the case of optionally substituted heteraryl, in the case of an optionally substituted aralkyl and in the case of an optionally substituted heterarylalkyl tube. The compounds of the present invention are useful for treating aging conditions such as Alzheimer's disease. ŕ |
| priorityDate | 1998-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 740.